Bleeding in acute promyelocytic leukemia (APL): fibrinolysis or defibrination? 1991

I Krsnik, and A Escribá, and M López-Rubio, and C Alarcón, and E del Potro, and J Díaz-Mediavilla
Servicio de Hematología, Hospital Clínico de San Carlos, Madrid, Espagne.

The coagulation abnormalities in 20 cases of acute promyelocytic leukemia (APL) treated at a single institution were reviewed. A remarkably uniform picture of defibrination and increased FDPs with well-preserved levels of other coagulation factors including AT-III was seen. Our data, together with those available in the literature, do not support DIC as the underlying mechanism of bleeding but seem rather to point to increased proteolysis as the cause.

UI MeSH Term Description Entries
D008297 Male Males
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D005260 Female Females
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015473 Leukemia, Promyelocytic, Acute An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION. Leukemia, Myeloid, Acute, M3,Leukemia, Progranulocytic,Myeloid Leukemia, Acute, M3,Progranulocytic Leukemia,Promyelocytic Leukemia, Acute,AML M3,Acute Promyelocytic Leukemia,Leukemia, Acute Promyelocytic,M3 ANLL,ANLL, M3,Acute Promyelocytic Leukemias

Related Publications

I Krsnik, and A Escribá, and M López-Rubio, and C Alarcón, and E del Potro, and J Díaz-Mediavilla
January 2019, [Rinsho ketsueki] The Japanese journal of clinical hematology,
I Krsnik, and A Escribá, and M López-Rubio, and C Alarcón, and E del Potro, and J Díaz-Mediavilla
April 1989, British journal of haematology,
I Krsnik, and A Escribá, and M López-Rubio, and C Alarcón, and E del Potro, and J Díaz-Mediavilla
February 1979, Cancer,
I Krsnik, and A Escribá, and M López-Rubio, and C Alarcón, and E del Potro, and J Díaz-Mediavilla
September 2002, Leukemia,
I Krsnik, and A Escribá, and M López-Rubio, and C Alarcón, and E del Potro, and J Díaz-Mediavilla
April 2004, Leukemia,
I Krsnik, and A Escribá, and M López-Rubio, and C Alarcón, and E del Potro, and J Díaz-Mediavilla
February 1983, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
I Krsnik, and A Escribá, and M López-Rubio, and C Alarcón, and E del Potro, and J Díaz-Mediavilla
August 1972, Annals of internal medicine,
I Krsnik, and A Escribá, and M López-Rubio, and C Alarcón, and E del Potro, and J Díaz-Mediavilla
June 2000, Thrombosis and haemostasis,
I Krsnik, and A Escribá, and M López-Rubio, and C Alarcón, and E del Potro, and J Díaz-Mediavilla
January 1998, Medical and pediatric oncology,
I Krsnik, and A Escribá, and M López-Rubio, and C Alarcón, and E del Potro, and J Díaz-Mediavilla
March 2020, Oncotarget,
Copied contents to your clipboard!